Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

A method of addressing proprietary name similarity for US prescription drugs.

Stockbridge MD, Taylor K. A Method of Addressing Proprietary Name Similarity for US Prescription Drugs. Ther Innov Regul Sci. 2015;49(4). doi:10.1177/2168479015570331.

Save
Print
August 19, 2015
Stockbridge MD, Taylor K. Ther Innov Regul Sci. 2015;49(4).
View more articles from the same authors.

Health care professionals can raise awareness of look-alike and sound-alike medication confusion by reporting mistakes when they occur in daily practice. This commentary provides information about the regulatory name assessment process to promote clinician reporting of problems associated with drug name similarity.

Save
Print
Cite
Citation

Stockbridge MD, Taylor K. A Method of Addressing Proprietary Name Similarity for US Prescription Drugs. Ther Innov Regul Sci. 2015;49(4). doi:10.1177/2168479015570331.

Related Resources From the Same Author(s)
Related Resources